Pharmaleads
Immeuble Paris BioPark
11 Rue Watt
75013 PARIS
Tel: +33 (0)1 44 06 70 00
fax: +33 (0)1 44 06 60 99
CONTACTEZ-NOUS

Return to Introduction to Pharmaleads substrates
FLUOFAST - faster and more accurate for lower HTS costs
CATALOGUE of Substrates/Inhibitors
Frequently Asked Questions on Pharmaleads substrates

The Fluofast® Protease Assay

The Fluofast® protease assay designed and patented by Pharmaleads is a unique and non radioactive method to discover an optimal substrate for all types of proteases. The Fluofast® protease assay combines very high sensitivity and speed required for protease detection and high-throughput screening for inhibitors or activators. Pharmaleads Fluofast® technology applies for identification of substrates for any given protease.

The library of 5000 substrates was obtained by introducing n amino acids, n ranging from 0 to 4, between the Pya and Nop compounds. The amino acids (X) are selected among a series of ten natural amino-acids.
The PHARMALEADS technology has been applied to rapidly detect substrates for all kinds of proteases belonging to metallo-, serine-, cystein- and aspartyl- protein classes. As an example in the figure besides, a restricted library (n=2) has been used to detect potential substrates for all classes of proteases. The intensity of the spots reflects the presence of cleavage(s) in each group of ten potential substrates. The identification of the metabolites by mass spectrometry gives the structure of the substrate hydrolysed. In case several substrates are hydrolysed, the choice of the best candidate will be made by comparing kinetic constants values and specificity.